Norges Bank
DNA icon

Norges Bank’s Ginkgo Bioworks DNA Stock Holding History

Norges Bank’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-390,696
Closed -$5.22M – 1871
2024
Q2 		$5.22M Buy
390,696
+3,671
+0.9% +$110K ﹤0.01% 1551
2024
Q1 		$18M Buy
387,025
+17,698
+5% +$916K ﹤0.01% 1297
2023
Q4 		$25M Buy
369,327
+29,052
+9% +$1.78M ﹤0.01% 1206
2023
Q3 		$24.6M Buy
340,275
+101,350
+42% +$8.1M 0.01% 1146
2023
Q2 		$17.8M Buy
238,925
+80,060
+50% +$4.74M ﹤0.01% 1305
2023
Q1 		$8.45M Sell
158,865
-37,976
-19% -$2.41M ﹤0.01% 1636
2022
Q4 		$13.3M Buy
196,841
+192,033
+3,994% +$17.7M ﹤0.01% 1455
2022
Q3 		$600K Buy
+4,808
New +$573K ﹤0.01% 2043

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return